{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:27:22Z","timestamp":1746332842508},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s00705-016-2955-z","type":"journal-article","created":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T05:23:28Z","timestamp":1467350608000},"page":"2503-2509","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Antiretroviral drug resistance mutations in na\u00efve and experienced patients in Shiraz, Iran, 2014"],"prefix":"10.1007","volume":"161","author":[{"given":"Hamed","family":"Naziri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazem","family":"Baesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdolvahab","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad R.","family":"Aghasadeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alijan","family":"Tabarraei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willi","family":"McFarland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad Ali","family":"Davarpanah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,1]]},"reference":[{"issue":"10","key":"2955_CR1","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMra025195","volume":"350","author":"F Clavel","year":"2004","unstructured":"Clavel F, Hance AJ (2004) HIV drug resistance. N Engl J Med 350(10):1023\u20131035","journal-title":"N Engl J Med"},{"issue":"4","key":"2955_CR2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3390\/v3040347","volume":"3","author":"KJ Cortez","year":"2011","unstructured":"Cortez KJ, Maldarelli F (2011) Clinical management of HIV drug resistance. Viruses 3(4):347\u2013378","journal-title":"Viruses"},{"issue":"10","key":"2955_CR3","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/01.aids.0000131310.52526.c7","volume":"18","author":"DD Richman","year":"2004","unstructured":"Richman DD, Morton SC, Wrin T, Hellmann N, Berry S, Shapiro MF et al (2004) The prevalence of antiretroviral drug resistance in the United States. Aids 18(10):1393\u20131401","journal-title":"Aids"},{"issue":"8","key":"2955_CR4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1473-3099(02)00343-2","volume":"2","author":"MM Thomson","year":"2002","unstructured":"Thomson MM, P\u00e9rez-\u00c1lvarez L, N\u00e1jera R (2002) Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis 2(8):461\u2013471","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"2955_CR5","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1086\/340130","volume":"185","author":"P Kaleebu","year":"2002","unstructured":"Kaleebu P, French N, Mahe C, Yirrell D, Watera C, Lyagoba F et al (2002) Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1\u2014positive persons in Uganda. J Infect Dis 185(9):1244\u20131250","journal-title":"J Infect Dis"},{"issue":"8","key":"2955_CR6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/00002030-199905280-00005","volume":"13","author":"A Alaeus","year":"1999","unstructured":"Alaeus A, Lidman K, Bj\u00f6rkman A, Giesecke J, Albert J (1999) Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes AD. Aids 13(8):901\u2013907","journal-title":"Aids"},{"issue":"11","key":"2955_CR7","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1097\/00002030-200007280-00004","volume":"14","author":"D Pieniazek","year":"2000","unstructured":"Pieniazek D, Rayfield M, Hu DJ, Nkengasong J, Wiktor SZ, Downing R et al (2000) Protease sequences from HIV-1 group M subtypes A\u2013H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide. Aids 14(11):1489\u20131495","journal-title":"Aids"},{"issue":"8","key":"2955_CR8","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/00002030-200205240-00007","volume":"16","author":"AJ Frater","year":"2002","unstructured":"Frater AJ, Dunn DT, Beardall AJ, Ariyoshi K, Clarke JR, McClure MO et al (2002) Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy. Aids 16(8):1139\u20131146","journal-title":"Aids"},{"key":"2955_CR9","unstructured":"Pennings PS (2012) HIV drug resistance: problems and perspectives. arXiv preprint arXiv:12115807"},{"issue":"1","key":"2955_CR10","first-page":"17","volume":"14","author":"D Frentz","year":"2012","unstructured":"Frentz D, Boucher C, Van De Vijver D (2012) Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world. AIDs Rev 14(1):17\u201327","journal-title":"AIDs Rev"},{"issue":"7","key":"2955_CR11","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/jmv.23898","volume":"86","author":"K Baesi","year":"2014","unstructured":"Baesi K, Ravanshad M, Ghanbarisafari M, Saberfar E, SeyedAlinaghi S, Volk JE (2014) Antiretroviral drug resistance among antiretroviral-na\u00efve and treatment experienced patients infected with HIV in Iran. J Med Virol 86(7):1093\u20131098","journal-title":"J Med Virol"},{"issue":"4","key":"2955_CR12","doi-asserted-by":"crossref","first-page":"e61864","DOI":"10.1371\/journal.pone.0061864","volume":"8","author":"F Jahanbakhsh","year":"2013","unstructured":"Jahanbakhsh F, Hattori J, Matsuda M, Ibe S, Monavari S-HR, Memarnejadian A et al (2013) Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011. PloS One 8(4):e61864","journal-title":"PloS One"},{"issue":"3","key":"2955_CR13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00705-009-0583-6","volume":"155","author":"SM Mousavi","year":"2010","unstructured":"Mousavi SM, Hamkar R, Gouya MM, Safaie A, Zahraei SM, Yazdani Z et al (2010) Surveillance of HIV drug resistance transmission in Iran: experience gained from a pilot study. Arch Virol 155(3):329\u2013334","journal-title":"Arch Virol"},{"issue":"9","key":"2955_CR14","doi-asserted-by":"crossref","first-page":"e105098","DOI":"10.1371\/journal.pone.0105098","volume":"9","author":"K Baesi","year":"2014","unstructured":"Baesi K, Moallemi S, Farrokhi M, Alinaghi SAS, Truong HHM (2014) Subtype classification of Iranian HIV-1 sequences registered in the HIV databases, 2006\u20132013. PloS One 9(9):e105098","journal-title":"PloS One"},{"key":"2955_CR15","unstructured":"Stuyver L (1999) Method for detection of drug-selected mutations in the HIV protease gene. Google Patents"},{"issue":"2","key":"2955_CR16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/JCM.36.2.569-572.1998","volume":"36","author":"RE Edelstein","year":"1998","unstructured":"Edelstein RE, Nickerson DA, Tobe VO, Manns-Arcuino LA, Frenkel LM (1998) Oligonucleotide ligation assay for detecting mutations in the human immunodeficiency virus type 1 polGene that are associated with resistance to zidovudine, didanosine, and lamivudine. J Clin Microbiol 36(2):569\u2013572","journal-title":"J Clin Microbiol"},{"issue":"1","key":"2955_CR17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/nar\/gkg100","volume":"31","author":"S-Y Rhee","year":"2003","unstructured":"Rhee S-Y, Gonzales MJ, Kantor R, Betts BJ, Ravela J, Shafer RW (2003) Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res 31(1):298\u2013303","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"2955_CR18","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/jmv.20634","volume":"78","author":"R Sarrami-Forooshani","year":"2006","unstructured":"Sarrami-Forooshani R, Das SR, Sabahi F, Adeli A, Esmaeili R, Wahren B et al (2006) Molecular analysis and phylogenetic characterization of HIV in Iran. J Med Virol 78(7):853\u2013863","journal-title":"J Med Virol"},{"key":"2955_CR19","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1097\/01.aids.0000386738.32919.67","volume":"24","author":"R Hamkar","year":"2010","unstructured":"Hamkar R, Mohraz M, Lorestani S, Aghakhani A, Truong H-HM, McFarland W et al (2010) Assessing subtype and drug-resistance-associated mutations among antiretroviral-treated HIV-infected patients. Aids 24:S85\u2013S91","journal-title":"Aids"},{"issue":"1","key":"2955_CR20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/aid.2008.0199","volume":"25","author":"ZS Soheilli","year":"2009","unstructured":"Soheilli ZS, Ataiee Z, Tootian S, Zadsar M, Amini S, Abadi K et al (2009) Presence of HIV-1 CRF35_AD in Iran. AIDS Res Hum Retrovir 25(1):123\u2013125","journal-title":"AIDS Res Hum Retrovir"},{"key":"2955_CR21","doi-asserted-by":"publisher","unstructured":"Baesi k, Moradbeigi M, Ravanshad M, Baghban A (2016) Phylogeny and drug resistance of HIV PR gene among HIV patients receiving RT inhibitors in Iran. Asian Pac J Trop Biomed. doi: 10.1016\/j.apjtb.2015.12.020","DOI":"10.1016\/j.apjtb.2015.12.020"},{"key":"2955_CR22","unstructured":"Gholami M, Sadeghi L, Baesi K, Rouzbahani NH, Mohraz M (2015) Survey of antiretroviral drug resistance pattern among HIV-infected patients with treatment failure in Iran. J Hum Virol Retrovir 3(1):1\u20136"},{"issue":"5","key":"2955_CR23","doi-asserted-by":"crossref","first-page":"e0126955","DOI":"10.1371\/journal.pone.0126955","volume":"10","author":"A Memarnejadian","year":"2015","unstructured":"Memarnejadian A, Menbari S, Mansouri SA, Sadeghi L, Vahabpour R, Aghasadeghi MR et al (2015) Transmitted drug resistance mutations in antiretroviral-na\u00efve injection drug users with chronic HIV-1 infection in Iran. PloS One 10(5):e0126955","journal-title":"PloS One"},{"issue":"6","key":"2955_CR24","doi-asserted-by":"crossref","first-page":"440","DOI":"10.7326\/0003-4819-134-6-200103200-00008","volume":"134","author":"MC Weinstein","year":"2001","unstructured":"Weinstein MC, Goldie SJ, Losina E, Cohen CJ, Baxter JD, Zhang H et al (2001) Use of genotypic resistance testing to guide HIV therapy: clinical impact and cost-effectiveness. Ann Intern Med 134(6):440\u2013450","journal-title":"Ann Intern Med"},{"issue":"3","key":"2955_CR25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1086\/510748","volume":"44","author":"D Smith","year":"2007","unstructured":"Smith D, Moini N, Pesano R, Cachay E, Aiem H, Lie Y et al (2007) Clinical utility of HIV standard genotyping among antiretroviral-naive individuals with unknown duration of infection. Clin Infect Dis 44(3):456\u2013458","journal-title":"Clin Infect Dis"},{"key":"2955_CR26","unstructured":"World Health Organization (2012) The HIV drug resistance report-2012. World Health Organization, Geneva"},{"issue":"10","key":"2955_CR27","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1086\/587109","volume":"46","author":"VC Marconi","year":"2008","unstructured":"Marconi VC, Sunpath H, Lu Z, Gordon M, Koranteng-Apeagyei K, Hampton J et al (2008) Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa. Clin Infect Dis 46(10):1589\u20131597","journal-title":"Clin Infect Dis"},{"key":"2955_CR28","unstructured":"Baesi K, Ravanshad M, Hosseini Y, Abdolbaghi MH (2012) Drug resistance profile and subtyping of HIV-1 RT gene in Iranian patients under treatment. Iran J Biotechnol 10(1)"},{"issue":"1","key":"2955_CR29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1086\/375781","volume":"188","author":"N Lee","year":"2003","unstructured":"Lee N, Hogg RS, Yip B, Harrigan PR, Harris M, O\u2019Shaughnessy MV et al (2003) Rates of disease progression among human immunodeficiency virus-infected persons initiating multiple-drug rescue therapy. J Infect Dis 188(1):137\u2013141","journal-title":"J Infect Dis"},{"issue":"6","key":"2955_CR30","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/infdis\/171.6.1411","volume":"171","author":"R Schuurman","year":"1995","unstructured":"Schuurman R, Nijhuis M, van Leeuwen R, Schipper P, de Jong D, Collis P et al (1995) Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC). J Infect Dis 171(6):1411\u20131419","journal-title":"J Infect Dis"},{"issue":"9171","key":"2955_CR31","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(98)12291-2","volume":"353","author":"J Durant","year":"1999","unstructured":"Durant J, Clevenbergh P, Halfon P, Delgiudice P, Porsin S, Simonet P et al (1999) Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomised controlled trial. Lancet 353(9171):2195\u20132199","journal-title":"Lancet"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-016-2955-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00705-016-2955-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-016-2955-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T05:17:19Z","timestamp":1600838239000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00705-016-2955-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,1]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["2955"],"URL":"https:\/\/doi.org\/10.1007\/s00705-016-2955-z","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,1]]}}}